Oluseun O. Alli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Oluseun O. Alli has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Mustafa I. Ahmed
Division of Cardiovascular Disease; University of Alabama at Birmingham; Birmingham Alabama
3 shared publications- Gautam Reddy
Department of Cardiovascular Diseases. Mayo Clinic, Rochester, Minnesota
2 shared publications - Navin Chander Nanda
Division of Cardiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA
2 shared publications - Christopher Roth
The University of Alabama at Birmingham
1 shared publication David R. Holmes
From the Division of Cardiovascular Diseases, The University of Alabama, Birmingham (G.R., J.E.D., S.P.S., O.O.A.); and Division of Cardiovascular Diseases, The Mayo Clinic, Rochester, MN (D.R.H., H.V.S.).
1 shared publication- Hartzell Vernon Schaff
Mayo Clinic
1 shared publication
Latest Publications
- Open Access
- 1 November 2015
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 8 (11) , e003062
Coronary Artery Fistulae
- 1 November 2015
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 8 (11) , e003062
Open AccessCoronary Artery Fistulae
- 7 March 2015
- Published by Springer Nature in Current Treatment Options in Neurology
- Vol. 17 (3) , 1-14
Role of Occlusive Devices to Prevent Thromboembolism Among Persons With a Patent Foramen Ovale and Prior Stroke
Patent foramen ovale (PFO) has been linked to stroke, presumably through the mechanism of paradoxical embolism; however, data is confusing regarding the causal relationship between PFO and embolic stroke. What has come to light in the past decade of research is that PFO closure with devices that achieve a high rate of closure may reduce the risk of recurrent stroke compared with medical therapy, but this benefit has not been shown in the general population with a PFO and cryptogenic stroke. The important question now is which patient will benefit from PFO closure for stroke risk reduction. A validated risk prediction tool is needed to help physicians determine those patients who will derive benefit from closure of PFO to prevent recurrent stroke. It is clear that even in studies with a small number of individuals and a very small number of events, there is some benefit to closure. Furthermore, improvements in closure devices and techniques have made percutaneous device closure both safe and efficacious. As such, it is not necessary to wait for a patient to have two strokes prior to serious consideration of PFO closure. We would advocate that the decision to close a PFO in the setting of a cryptogenic stroke be made at an individual level, on a case-by-case basis. Patients with high-risk features may be more likely to benefit, though who exactly comprises this population is still being elucidated. The most difficult aspect of managing this disease is the substantial number of individuals with incidental PFOs, as well as the prevalence of stroke due to other etiologies. When treating this disease, the physician must be able to weigh the likelihood of benefit versus the risk of the procedure, as well as patient preference.
- 7 March 2015
- Published by Springer Nature in Current Treatment Options in Neurology
- Vol. 17 (3) , 1-14
Role of Occlusive Devices to Prevent Thromboembolism Among Persons With a Patent Foramen Ovale and Prior Stroke
Patent foramen ovale (PFO) has been linked to stroke, presumably through the mechanism of paradoxical embolism; however, data is confusing regarding the causal relationship between PFO and embolic stroke. What has come to light in the past decade of research is that PFO closure with devices that achieve a high rate of closure may reduce the risk of recurrent stroke compared with medical therapy, but this benefit has not been shown in the general population with a PFO and cryptogenic stroke. The important question now is which patient will benefit from PFO closure for stroke risk reduction. A validated risk prediction tool is needed to help physicians determine those patients who will derive benefit from closure of PFO to prevent recurrent stroke. It is clear that even in studies with a small number of individuals and a very small number of events, there is some benefit to closure. Furthermore, improvements in closure devices and techniques have made percutaneous device closure both safe and efficacious. As such, it is not necessary to wait for a patient to have two strokes prior to serious consideration of PFO closure. We would advocate that the decision to close a PFO in the setting of a cryptogenic stroke be made at an individual level, on a case-by-case basis. Patients with high-risk features may be more likely to benefit, though who exactly comprises this population is still being elucidated. The most difficult aspect of managing this disease is the substantial number of individuals with incidental PFOs, as well as the prevalence of stroke due to other etiologies. When treating this disease, the physician must be able to weigh the likelihood of benefit versus the risk of the procedure, as well as patient preference.
- 1 October 2014
- Published by Wiley in Echocardiography
- Vol. 31 (9) , 1154-1158
Incremental Value of Three-Dimensional Transesophageal Echocardiography over the Two-Dimensional Technique in Percutaneous Closure of Aortic Paraprosthetic Regurgitation
We describe 2 patients with significant aortic paraprosthetic regurgitation who underwent percutaneous closure where live/real time three‐dimensional transesophageal echocardiography provided incremental value over two‐dimensional transesophageal echocardiography.
- 1 October 2014
- Published by Wiley in Echocardiography
- Vol. 31 (9) , 1154-1158
Incremental Value of Three-Dimensional Transesophageal Echocardiography over the Two-Dimensional Technique in Percutaneous Closure of Aortic Paraprosthetic Regurgitation
We describe 2 patients with significant aortic paraprosthetic regurgitation who underwent percutaneous closure where live/real time three‐dimensional transesophageal echocardiography provided incremental value over two‐dimensional transesophageal echocardiography.
- Open Access
- 10 April 2014
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 35 (30) , 2031
Combined intracardiac and epicardial device closure of a large left ventricular pseudoaneurysm
An 81-year-old man with a history of coronary artery bypass grafting presented with left ventricular anterolateral free wall rupture with formation of a large left ventricular pseudoaneurysm. He was referred to us for catheter-based repair as he was felt to be high risk for poor outcome with surgical repair. Pre-procedural CT scan (Panel A) and intra-procedural cine-angiography (Panel B) clearly demonstrated a large left ventricular pseudoaneurysm. Initially a retrograde aortic approach was used to place an 18 mm ASO device with satisfactory device seating confirmed by fluoroscopy (Panel C). Surprisingly, when the patient returned for 2-week follow-up, CT scan demonstrated enlargement of the pseudoaneurysm despite the device appearing to be nicely seated (Panel D) as also demonstrated on cine-angiography (Panel E). An alternative approach was then necessitated, with direct puncture of the pseudoaneurysm through the left chest (Panel F) and coil embolization of the pseudoaneurysm (Panels G and H). The puncture site was closed with an 8 mm Amplatz Vascular Plug II (Panel H, arrow). He did well post-procedure and follow-up CT scan showed complete occlusion of the pseudoaneurysm with no further enlargement (Panel I).
- 10 April 2014
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 35 (30) , 2031
Open AccessCombined intracardiac and epicardial device closure of a large left ventricular pseudoaneurysm
An 81-year-old man with a history of coronary artery bypass grafting presented with left ventricular anterolateral free wall rupture with formation of a large left ventricular pseudoaneurysm. He was referred to us for catheter-based repair as he was felt to be high risk for poor outcome with surgical repair. Pre-procedural CT scan (Panel A) and intra-procedural cine-angiography (Panel B) clearly demonstrated a large left ventricular pseudoaneurysm. Initially a retrograde aortic approach was used to place an 18 mm ASO device with satisfactory device seating confirmed by fluoroscopy (Panel C). Surprisingly, when the patient returned for 2-week follow-up, CT scan demonstrated enlargement of the pseudoaneurysm despite the device appearing to be nicely seated (Panel D) as also demonstrated on cine-angiography (Panel E). An alternative approach was then necessitated, with direct puncture of the pseudoaneurysm through the left chest (Panel F) and coil embolization of the pseudoaneurysm (Panels G and H). The puncture site was closed with an 8 mm Amplatz Vascular Plug II (Panel H, arrow). He did well post-procedure and follow-up CT scan showed complete occlusion of the pseudoaneurysm with no further enlargement (Panel I).
- 20 March 2014
- Published by Wiley in Echocardiography
- Vol. 31 (4) , 531-533
Utility of Live/Real Time Three‐Dimensional Transesophageal Echocardiography in the Assessment and Percutaneous Intervention of Bioprosthetic Pulmonary Valve Stenosis
Accurate echocardiographic evaluation of the pulmonary valve is technically difficult because of its close proximity to the left lung, which often limits decision making. Pulmonary valvotomy is the intervention of choice for symptomatic pulmonary valve stenosis, but fluoroscopy lacks appropriate real time anatomic detail. In this report, we present a case where direct imaging of the pulmonary valve with live/real time three-dimensional transesophageal echocardiography (3DTEE) aided in accurate evaluation and was then used to help guide and monitor successful valvuloplasty of a stenotic pulmonary valve bioprosthesis. We demonstrate that even in cases where two-dimensional (2D) evaluation of the pulmonary valve is difficult, the use of live/real time 3DTEE allows for accurate evaluation of bioprosthetic pulmonary valve structure and function, and enhances the precision and monitoring of percutaneous valvuloplasty.
- 20 March 2014
- Published by Wiley in Echocardiography
- Vol. 31 (4) , 531-533
Utility of Live/Real Time Three‐Dimensional Transesophageal Echocardiography in the Assessment and Percutaneous Intervention of Bioprosthetic Pulmonary Valve Stenosis
Accurate echocardiographic evaluation of the pulmonary valve is technically difficult because of its close proximity to the left lung, which often limits decision making. Pulmonary valvotomy is the intervention of choice for symptomatic pulmonary valve stenosis, but fluoroscopy lacks appropriate real time anatomic detail. In this report, we present a case where direct imaging of the pulmonary valve with live/real time three-dimensional transesophageal echocardiography (3DTEE) aided in accurate evaluation and was then used to help guide and monitor successful valvuloplasty of a stenotic pulmonary valve bioprosthesis. We demonstrate that even in cases where two-dimensional (2D) evaluation of the pulmonary valve is difficult, the use of live/real time 3DTEE allows for accurate evaluation of bioprosthetic pulmonary valve structure and function, and enhances the precision and monitoring of percutaneous valvuloplasty.
- 31 January 2014
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 85 (5) , 925-929
Percutaneous valvuloplasty for severe bioprosthetic tricuspid valve stenosis in the setting of infective endocarditis
Bioprosthetic tricuspid valve stenosis as a sequela of infective endocarditis is extremely rare. We describe the case of a 29‐year‐old male patient with a history of intravenous drug use and two previous bioprosthetic tricuspid valve placements who presented with recurrent endocarditis and severe tricuspid stenosis. He was deemed extremely high risk for redo valve replacement surgery. Intracardiac ultrasound‐guided balloon valvuloplasty was performed with good clinical outcome. We believe that interventional treatment of prosthetic valvular stenosis in the setting of endocarditis is a reasonable therapeutic choice when open surgical repair is associated with prohibitively high mortality. This can be performed either as destination therapy or as a bridge to valve replacement. The use of intracardiac ultrasound provided additive information to that obtained by transthoracic and transesophageal echocardiography.
- 31 January 2014
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 85 (5) , 925-929
Percutaneous valvuloplasty for severe bioprosthetic tricuspid valve stenosis in the setting of infective endocarditis
Bioprosthetic tricuspid valve stenosis as a sequela of infective endocarditis is extremely rare. We describe the case of a 29‐year‐old male patient with a history of intravenous drug use and two previous bioprosthetic tricuspid valve placements who presented with recurrent endocarditis and severe tricuspid stenosis. He was deemed extremely high risk for redo valve replacement surgery. Intracardiac ultrasound‐guided balloon valvuloplasty was performed with good clinical outcome. We believe that interventional treatment of prosthetic valvular stenosis in the setting of endocarditis is a reasonable therapeutic choice when open surgical repair is associated with prohibitively high mortality. This can be performed either as destination therapy or as a bridge to valve replacement. The use of intracardiac ultrasound provided additive information to that obtained by transthoracic and transesophageal echocardiography.